HIV GLYCOPROTEIN-41 AND COMPLEMENT FACTOR-H INTERACT WITH EACH OTHER AND SHARE FUNCTIONAL AS WELL AS ANTIGENIC HOMOLOGY

被引:46
作者
PINTER, C
SICCARDI, AG
LOPALCO, L
LONGHI, R
CLIVIO, A
机构
[1] UNIV MILAN,LITA VIALBA,DIPARTIMENTO BIOL & GENET SCI MED,MILAN,ITALY
[2] DIBIT SAN RAFFAELE,MILAN,ITALY
[3] CNR,IST CHIM ORMONI,MILAN,ITALY
关键词
D O I
10.1089/aid.1995.11.971
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We have shown that complement factor H (CFH) interacts with HIV-1 at the level of the sequence Env 105-119, contained in the C1 domain of gp120. CFH interaction with HIV was evident only after dissociation of the Env complex induced by exposure to sCD4, We hypothesized that CFH could act as a gp41 analog in the interaction with Env 105-119. A panel of partially overlapping, synthetic peptides reproducing the extracellular portion of gp41 was therefore used to compete the binding of CFH to Env 105-119. Three sets of peptides that competed this interaction were identified. These peptides defined a region of functional homology between the gp41 molecule and CFH (Env 580-600), and two regions of interaction (Env 620-640 and Env 650-670), In addition to this, a monoclonal antibody directed against peptide Env 580-600 and a polyclonal mouse antiserum raised against recombinant gp41 were shown to recognize CFH in Western blots and ELISA, respectively, also defining a region of antigenic homology between gp41 and CFH. These data provide evidence for interaction and molecular mimicry between an HIV structural protein and a negative regulator of the complement pathway. We show here that CFH can interact with both HIV Env proteins, suggesting a possible and efficient mechanism of downregulation of the complement cascade at the surface of infected cells.
引用
收藏
页码:971 / 980
页数:10
相关论文
共 47 条
[21]   SPECTROSCOPIC EVIDENCE THAT MONOCLONAL-ANTIBODIES RECOGNIZE THE DOMINANT CONFORMATION OF MEDIUM-SIZED SYNTHETIC PEPTIDES [J].
LANG, E ;
SZENDREI, GI ;
LEE, VMY ;
OTVOS, L .
JOURNAL OF IMMUNOLOGICAL METHODS, 1994, 170 (01) :103-115
[22]  
LONGHI R, 1993, PEPTIDES 1992, P569
[23]   IDENTIFICATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GLYCOPROTEIN-GP120/GP41 INTERACTING SITES BY THE IDIOTYPIC MIMICRY OF 2 MONOCLONAL-ANTIBODIES [J].
LOPALCO, L ;
LONGHI, R ;
CICCOMASCOLO, F ;
DEROSSI, A ;
PELAGI, M ;
ANDRONICO, F ;
MOORE, JP ;
SCHULZ, T ;
BERETTA, A ;
SICCARDI, AG .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1993, 9 (01) :33-39
[24]   HIV-1 AND HIV-2 ISOLATES DIFFER IN THEIR ABILITY TO ACTIVATE THE COMPLEMENT-SYSTEM ON THE SURFACE OF INFECTED-CELLS [J].
MARSCHANG, P ;
GURTLER, L ;
TOTSCH, M ;
THIELENS, NM ;
ARLAUD, GJ ;
HITTMAIR, A ;
KATINGER, H ;
DIERICH, MP .
AIDS, 1993, 7 (07) :903-910
[25]   BINDING OF HTLV-III/LAV TO T4+ T-CELLS BY A COMPLEX OF THE 110K VIRAL PROTEIN AND THE T4 MOLECULE [J].
MCDOUGAL, JS ;
KENNEDY, MS ;
SLIGH, JM ;
CORT, SP ;
MAWLE, A ;
NICHOLSON, JKA .
SCIENCE, 1986, 231 (4736) :382-385
[26]  
Merrifield RB, 1976, SCIENCE, V232, P341, DOI DOI 10.1126/SCIENCE.3961484
[27]   COMPLEMENT CONTROL PROTEINS, CD46, CD55, AND CD59, AS COMMON SURFACE CONSTITUENTS OF HUMAN AND SIMIAN IMMUNODEFICIENCY VIRUSES AND POSSIBLE TARGETS FOR VACCINE PROTECTION [J].
MONTEFIORI, DC ;
CORNELL, RJ ;
ZHOU, JY ;
ZHOU, JT ;
HIRSCH, VM ;
JOHNSON, PR .
VIROLOGY, 1994, 205 (01) :82-92
[28]   SYNTHETIC PEPTIDES AND ANTIPEPTIDE ANTIBODIES AS PROBES TO STUDY INTERDOMAIN INTERACTIONS INVOLVED IN VIRUS ASSEMBLY - THE ENVELOPE OF THE HUMAN-IMMUNODEFICIENCY-VIRUS (HIV-1) [J].
NEURATH, AR ;
STRICK, N ;
JIANG, S .
VIROLOGY, 1992, 188 (01) :1-13
[29]  
PANGBURN MK, 1991, J BIOL CHEM, V266, P16847
[30]   HUMAN COMPLEMENT C3B INACTIVATOR - ISOLATION, CHARACTERIZATION, AND DEMONSTRATION OF AN ABSOLUTE REQUIREMENT FOR SERUM-PROTEIN BETA-1H FOR CLEAVAGE OF C3B AND C4B IN SOLUTION [J].
PANGBURN, MK ;
SCHREIBER, RD ;
MULLEREBERHARD, HJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 1977, 146 (01) :257-270